
Background/Objectives: Zika virus (ZIKV) infection remains an important public health concern due to its association with neurological complications and congenital malformations. This study aimed to analyze the epidemiological profile of reported ZIKV cases in Brazil between 2015 and 2025. Methods: This was a retrospective ecological time-series study using secondary data from the Notifiable Diseases Information System (SINAN/DATASUS). Temporal, spatial, and demographic distributions were analyzed, as well as cumulative incidence and case fatality according to age. Results: Between 2015 and 2025, 193,194 confirmed ZIKV cases were reported in Brazil. Significant annual variation was observed (χ2 = 920.675; df = 10; p < 0.0001), with a marked peak in 2016 (n = 138,025; 71.4%), followed by a substantial decline. The distribution across macro-regions was significantly heterogeneous (χ2 = 55.509; df = 4; p < 0.0001), with the Southeast (n = 84,107; 43.5%) and Northeast (n = 56,882; 29.4%) accounting for the highest absolute numbers of cases. Cases were predominant among females (n = 129,426; 67.0%; 95% CI: 66.78–67.20%; p < 0.0001) and adults aged 20–39 years (n = 81,661; 42.3%). The overall case fatality was 0.04%, with significant age-related (χ2 = 98.30; df = 4; p < 0.0001), the highest case fatality rates occurred among children younger than 1 year (0.35%) followed by individuals aged 1–19 years and those aged ≥60 years, both with a case fatality rate of 0.05%. Conclusions: ZIKV transmission in Brazil showed marked temporal, geographic, and demographic heterogeneity. Although cases declined after the 2016 epidemic peak, ZIKV remains an important public health concern, with persistent regional differences in disease burden.
Background/Objective: Non-communicable diseases and mental health conditions impose a growing burden on working-age adults, yet prevention strategies remain fragmented and rarely personalized. This study describes the development of an evidence-informed framework integrating multi-domain health assessment and psychological risk stratification to support personalized prevention in adults aged 18–65 years. Methods: National behavioral surveillance data (PASSI 2023–2024) and occupational disease data (INAIL 2024) were examined to inform the framework. Validated assessment instruments were selected across relevant health domains according to their applicability to the target population. A user-centered and participatory design approach was also incorporated into the DELPHI (Digital Engagement for Lifelong Prevention and Health Improvement) project. Results: The epidemiological evidence highlighted persistent behavioral risk factors and social inequalities among working-age adults. The resulting framework comprises seven assessment domains, integrating validated instruments to characterize participants’ health status and modifiable risk factors. Psychological risk indicators were used to define two personalized prevention pathways, “Maintenance” and “Rebalancing”, with periodic reassessment. Conclusions: The DELPHI framework integrates multi-domain health assessment with psychological risk-based personalization to support preventive interventions in working-age adults. The clinical trial is ongoing; its outcomes, usability and effectiveness will be evaluated upon completion of the project.
Background: Nontuberculous mycobacterial pulmonary disease (NTM-PD) is increasing worldwide, but data from high tuberculosis (TB)-burden Balkan countries are scarce. Methods: We retrospectively analyzed all sputum cultures negative for MPT64 (an M. tuberculosis complex-specific antigen) at the Romanian National Reference Laboratory in 2022. Species were identified by line probe assay; the microbiological criterion for NTM-PD was ≥2 sputum cultures with the same NTM species. Results: Of 1512 positive cultures, 142 (9.4%) were MPT64-negative, originating from 117 patients. One isolate was M. canettii. Among 140 NTM isolates, 55.7% were rapidly growing mycobacteria, led by the M. fortuitum group (27.9%), the M. abscessus complex (16.4%), and M. avium (15.7%). Twenty-nine patients (24.8%) met the microbiological criterion, of whom 21 were treated. Cavitary disease (14/21 vs. 0/8; p = 0.002) and prior TB (13/21 vs. 0/8; p = 0.003) occurred only in treated patients. Only 7 treated patients (33.3%) received a macrolide. Using national TB program categories, the outcome was favorable in 16/21 patients (76.2%), and 3 patients died (14.3%). Conclusions: About one quarter of patients with an NTM isolate met the microbiological criterion for NTM-PD. Treatment targeted cavitary and post-tuberculous disease, but regimens were often not species-appropriate, supporting a dedicated national NTM-PD protocol.
Background/Objective: Influenza vaccination is recommended for patients at increased cardiovascular risk. Yet, despite Lithuania’s high cardiovascular mortality, it remains unclear whether uptake is higher among patients at greater cardiovascular risk, particularly those receiving secondary prevention. Vaccination uptake and its associated factors were assessed among statin users, a population at increased cardiovascular risk. Methods: A nationwide registry-based cohort study of Lithuanian statin users was conducted using national e-health records covering the 2020/21 to 2025/26 influenza seasons (1 September to 31 May). Patients were classified into primary- and secondary-prevention groups based on prescription indications coded according to ICD-10-AM. Factors associated with vaccination uptake were examined via multivariable logistic regression. Results: The final cohort included 812,086 unique statin users (81.6% primary, 18.4% secondary prevention). Crude uptake was higher among secondary-prevention (~21%) than primary-prevention patients (~14%; OR 1.73, 95% CI 1.71–1.75); after adjustment for age, prior vaccination and other covariates, the association was small (aOR 1.07, 95% CI 1.06–1.08). A documented prior influenza vaccination was strongly associated with vaccination (aOR 22.18, 95% CI 21.95–22.41). Statin non-persistence (aOR 0.76) and non-initiation (aOR 0.61) were associated with lower odds of vaccination. Conclusions: Influenza vaccination uptake only slightly differed among prevention groups and remained below the WHO 75% coverage target, suggesting that cardiovascular risk status may add little to vaccination uptake beyond age and vaccination history. Prior vaccination and statin treatment persistence were strongly associated with vaccination. This may reflect a shared pattern of engagement with preventive care, but engagement was not measured, and this interpretation remains a hypothesis. Whether bundling vaccination promotion with medication reviews, or involving pharmacists, would raise uptake in higher-risk patients needs to be tested.
Background and Objectives: Family physicians are central to HPV vaccination delivery in Romania, yet little is known about how they perceive recent changes in parental attitudes and the barriers encountered in routine practice. We described these perceptions and examined factors associated with reporting a perceived change. Materials and Methods: A cross-sectional online survey of a non-probability convenience sample of 525 primary-care physicians was conducted in February 2025. Closed responses were summarised descriptively, free-text responses underwent structured thematic content analysis, and robust Poisson regression estimated adjusted prevalence ratios (aPRs), with nominal inference. Results: Amongst respondents, 82.9% reported perceiving a change in parental attitudes; 67.4% provided content meeting a conservative favourable-coding definition and 76.8% a broader definition. Safety concerns and fear (51.9%) and distrust or resistance (46.8%) were the most frequent barriers. Digital sources were perceived as the principal origins of myths (95.6%). Urban respondents reported perceived change more often than rural respondents (88.2% versus 69.9%; aPR 1.265, 95% CI 1.133–1.413; p < 0.001), with similar estimates across sensitivity analyses. Conclusions: In this convenience sample, most physicians reported perceiving changes in parental attitudes and many descriptions were coded as favourable. These reports generate hypotheses for studies using direct parental measures and documented vaccination outcomes.